Advertisement
Screener

WEST PHARMACEUTICAL SERVICES, INC. (WST) Other Non-Current Assets

2.8 / 5 stars · 68/120 Roast Me

WEST PHARMACEUTICAL SERVICES, INC. Other Non-Current Assets

WEST PHARMACEUTICAL SERVICES, INC. (WST) had Other Non-Current Assets of $82.80 million as of 2026-06-30, per its 10-Q filed 2026-07-23.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:OtherAssetsNoncurrent · last filed 2026-07-23

  • 2026-06-30: Other Assets, Noncurrent $82.80M.
  • 2026-03-31: Other Assets, Noncurrent $81.30M.
  • 2025-12-31: Other Assets, Noncurrent $80.10M.
  • 2025-09-30: Other Assets, Noncurrent $75.80M.
Period endOther Assets, NoncurrentOther Assets, Noncurrent as first filed
2026-06-30$82.80M
10-Q · filed 2026-07-23
2026-03-31$81.30M
10-Q · filed 2026-04-23
2025-12-31$80.10M
10-Q · filed 2026-07-23
2025-09-30$75.80M
10-Q · filed 2025-10-23
2025-06-30$70.50M
10-Q · filed 2025-07-24
2025-03-31$70.20M
10-Q · filed 2025-04-24
2024-12-31$74.30M
10-K · filed 2026-02-17
2024-09-30$69.30M
10-Q · filed 2024-10-24
2024-06-30$50.10M
10-Q · filed 2024-07-25
2024-03-31$19.00M
10-Q · filed 2024-04-25
2023-12-31$21.30M
10-K · filed 2025-02-18
2023-09-30$38.80M
10-Q · filed 2023-10-26
2023-06-30$40.30M
10-Q · filed 2023-07-27
2023-03-31$36.70M
10-Q · filed 2023-04-27
2022-12-31$38.40M
10-K · filed 2024-02-20
$38.10M
10-K · filed 2023-02-21
2022-09-30$52.70M
10-Q · filed 2022-10-27
2022-06-30$49.40M
10-Q · filed 2022-07-28
2022-03-31$40.50M
10-Q · filed 2022-04-28
2021-12-31$39.20M
10-K · filed 2023-02-21
2021-09-30$31.60M
10-Q · filed 2021-10-28
2021-06-30$26.30M
10-Q · filed 2021-07-30
2021-03-31$24.80M
10-Q · filed 2021-04-30
2020-12-31$23.40M
10-K · filed 2022-02-22
2020-09-30$21.80M
10-Q · filed 2020-10-23
2020-06-30$21.30M
10-Q · filed 2020-07-24
2020-03-31$22.00M
10-Q · filed 2020-04-24
2019-12-31$24.70M
10-K · filed 2021-02-23
2019-09-30$20.00M
10-Q · filed 2019-10-29
2019-06-30$20.30M
10-Q · filed 2019-07-29
2019-03-31$26.40M
10-Q · filed 2019-05-08
2018-12-31$20.50M
10-K · filed 2020-02-24
2018-09-30$21.70M
10-Q · filed 2018-10-30
2018-06-30$21.50M
10-Q · filed 2018-07-31
2018-03-31$21.90M
10-Q · filed 2018-05-08
2017-12-31$23.40M
10-K · filed 2019-02-28
2017-09-30$16.70M
10-Q · filed 2017-10-31
2017-06-30$16.00M
10-Q · filed 2017-08-01
2017-03-31$21.50M
10-Q · filed 2017-05-05
2016-12-31$21.30M
10-K · filed 2018-02-26
2016-09-30$22.80M
10-Q · filed 2016-10-31
2016-06-30$22.50M
10-Q · filed 2016-08-01
2016-03-31$24.00M
10-Q · filed 2016-05-06
2015-12-31$26.40M
10-K · filed 2017-02-28
2015-09-30$25.70M
10-Q · filed 2015-11-02
2015-06-30$27.40M
10-Q · filed 2015-08-03
2015-03-31$27.10M
10-Q · filed 2015-05-06
2014-12-31$27.50M
10-K · filed 2016-02-26
$28.50M
10-K · filed 2015-02-25
2014-09-30$22.90M
10-Q · filed 2014-11-03
2014-06-30$24.10M
10-Q · filed 2014-08-01
2014-03-31$23.70M
10-Q · filed 2014-05-08
2013-12-31$24.00M
10-K · filed 2015-02-25
2013-09-30$25.60M
10-Q · filed 2013-11-04
2013-06-30$25.20M
10-Q · filed 2013-08-05
2013-03-31$24.10M
10-Q · filed 2013-05-06
2012-12-31$24.50M
10-K · filed 2014-02-27
2012-09-30$24.50M
10-Q · filed 2012-11-05
2012-06-30$24.50M
10-Q · filed 2012-08-06
2012-03-31$28.70M
10-Q · filed 2012-05-04
2011-12-31$28.70M
10-K · filed 2013-02-27
2011-09-30$29.10M
10-Q · filed 2011-11-07
2011-06-30$30.00M
10-Q/A · filed 2011-08-08
2011-03-31$22.90M
10-Q · filed 2011-05-05
2010-12-31$22.60M
10-K/A · filed 2012-03-01
2010-09-30$20.30M
10-Q · filed 2010-11-05
2010-06-30$22.00M
10-Q · filed 2010-08-05
2009-12-31$19.30M
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44